Biotech

All Articles

Arch closes $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund from Bain Capital Lifestyle Sciences, Arc Project Partners is act...

Orion to make use of Aitia's 'digital twins' to find brand-new cancer medicines

.Finnish biotech Orion has actually snooped possible in Aitia's "digital double" tech to cultivate b...

Windtree's shock med rears blood pressure in most current phase 2 succeed

.While Windtree Therapeutics has actually battled to increase the economic origins needed to survive...

2 cancer cells biotechs merge, generating international footprint

.OncoC4 is actually taking AcroImmune-- as well as its in-house scientific manufacturing abilities--...

Amgen reports 1st period 3 gain for $400M chronic eczema medicine

.Amgen has actually discussed (PDF) the first period 3 records on its own $400 million dermatitis me...

Biogen, UCB document period 3 lupus succeed after falling short earlier trial

.Biogen as well as UCB's rely on improving right into phase 3 astride an unsuccessful research study...

Aptadir really hopes new RNA preventions can turn around tricky cancers

.Italian biotech Aptadir Therapies has actually launched with the guarantee that its pipe of preclin...

Wave surfs DMD effectiveness to regulators' doors, sending stockpile

.Surge Life Sciences has actually met its objective in a Duchenne muscular dystrophy (DMD) study, po...

Sanofi tweezes brand-new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, using up the ...

Achilles splashes tissue treatment program, braces for layoffs after overlooking 'commercial practicality' objectives

.Achilles Therapeutics has torn up its own method. The British biotech is actually knocking off on i...